Clinical trial · Observational
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
NCT05635266CI-TRIAL-00076842unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.
Conditions
Conditions (47)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Age-Related Macular Degeneration | — | UNRESOLVED | — |
| Allergies | — | UNRESOLVED | — |
| Alopecia Areata | — | UNRESOLVED | — |
| Alpha-Gal Syndrome | — | UNRESOLVED | — |
| ALS | — | UNRESOLVED | — |
| Alzheimer Disease | — | UNRESOLVED | — |
| Amyloidosis | Amyloidosis | ONTOLOGY_EXACT | 0.98 |
| Ankylosing Spondylitis | — | UNRESOLVED | — |
| Arthritis | — | UNRESOLVED | — |
| Asthma | — | UNRESOLVED | — |
| Atopic Dermatitis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Specimen sample | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Health Condition Group
- interventionNames
- Diagnostic Test: Specimen sample
- label
- Exceptive Condition Group
- interventionNames
- Diagnostic Test: Specimen sample
- label
- Control Group
- interventionNames
- Diagnostic Test: Specimen sample
Primary outcomes (1)
- measure
- Biospecimen & Clinical Data Collection
- timeFrame
- 10 years
- description
- To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Persons 18 to 85 years of age at the date of informed consent. * If presenting with a history of a specific condition, the diagnosis is confirmable in the medical record or may be confirmed using other forms of verification including self-reporting. * Understands the procedures and requirements of the study by providing written informed consent (or verbal assent if a legally authorized representative will sign the ICF), including consent for authorization for protected health information disclosure. Exclusion Criteria: * Persons younger than 18 years of age or older than 85 years of age at the date of informed consent. * Receipt of blood products 30 days before the study blood draw. * Receipt of an investigational (unapproved) drug 30 days before the study blood draw. * A confirmable diagnosis of any medical condition that would increase potential phlebotomy risks. * Has donated a unit of blood within the last 2 months at the date of informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.